MB04 is a biosimilar medication being studied for treating rheumatoid arthritis. It is designed to work similarly to Enbrel in reducing joint inflammation and managing arthritis symptoms.

Enbrel (etanercept) is a medication used to treat rheumatoid arthritis by reducing inflammation in the joints. It works by blocking a substance in the body that causes inflammation.

Methotrexate is a medication commonly used to treat rheumatoid arthritis. It helps reduce pain, swelling, and stiffness in the joints by suppressing the immune system’s inflammatory response.

Rheumatoid Arthritis – A chronic inflammatory disease that primarily affects the joints throughout the body. The condition causes the immune system to mistakenly attack the body’s own tissues, particularly the lining of joint capsules, leading to inflammation and swelling. Over time, this ongoing inflammation can cause thickening of the joint lining, destruction of cartilage and bone within the joint, and gradual loss of joint function. The disease typically affects multiple joints symmetrically, meaning if one hand is affected, the other usually is too. Rheumatoid arthritis commonly begins in the small joints of the hands and feet, but can spread to larger joints like knees, hips, and shoulders. The condition often develops gradually, with symptoms including joint pain, stiffness (especially in the morning), swelling, and warmth in affected areas.